Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-serine for PTSD
NCT00215878Phase 2Completed
- Sponsor
- Herzog Hospital
- Start
- Aug 2003
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of d-serine in post-traumatic stress disorder (PTSD) (2 arms), sponsored by Herzog Hospital. Primary endpoint: Clinician-Administered PTSD Scale at 6 weeks. Started Aug 2003; status: completed.
02
Drugs
d-serine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00215878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00215878.